Humana Inc. (HUM)
After hours:
| Previous close | 327.98 |
| Open | 335.00 |
| Bid | 310.15 x 800 |
| Ask | 317.50 x 1200 |
| Day's range | 309.00 - 336.40 |
| 52-week range | 299.23 - 541.21 |
| Volume | |
| Avg. volume | 1,785,435 |
| Market cap | 39.538B |
| Beta (5Y monthly) | 0.46 |
| PE ratio (TTM) | 15.79 |
| EPS (TTM) | N/A |
| Earnings date | N/A |
| Forward dividend & yield | 3.54 (1.08%) |
| Ex-dividend date | 28 June 2024 |
| 1y target est | N/A |
- Yahoo Finance Video
Humana stock slides on pullback for 2025 forecast
Shares of Humana (HUM) slide Wednesday morning as the health insurance company reported its first-quarter earnings, revealing $29.61 billion in total revenue for the quarter, an increase of 10% year-over-year, however, the company pulled back its full-year 2025 forecast. The company cites disappointing Medicare reimbursement rates from the US government as a reason for the pullback. Yahoo Finance Health Reporter Anjalee Khemlani breaks down the first-quarter results and what challenges the insurer faces moving forward. For more expert insight and the latest market action, click here to watch this full episode. This post was written by Nicholas Jacobino
- Zacks
Premium Growth Propels Humana (HUM) to Easy Q1 Earnings Beat
Humana (HUM) bumps up individual Medicare Advantage membership growth guidance.
- GuruFocus.com
Humana Inc (HUM) Reports Mixed Q1 2024 Results; Revises Full-Year EPS Guidance
Despite Challenges, Company Affirms Adjusted EPS and Raises Medicare Advantage Membership Growth Forecast
